CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF MURAMYL DIPEPTIDE IN THE TREATMENT OF ATOPIC DISEASES
https://doi.org/10.15789/1563-0625-2016-1-15-20
Abstract
Increased incidence of allergic diseases worldwide reflects some mangles of the existing pharmacotherapy concept which ignores some etiopathogenetic aspects of clinical atopy. Meanwhile, understanding cellular and molecular mechanisms of allergy may create prerequisites for development of new therapeutic areas, in order to effectively influence pathogenesis points of allergic inflammation and, thus, leading to therapeutic success. The review article concerns an antagonism between the two populations of T-helper cells (Th1 and Th2) carried out mainly by the action of IFNγ produced by activated Th1, and IL-4 secreted by activated Th2 which is at the heart of modern concept on the regulation of adaptive immunity. The prospects of immunotherapy of allergic diseases based on the polarization of the immune response are discussed, i.e., an activation of Th1 responses and Th2 suppression. This functional polarization can be mediated by the innate immune receptor agonist, i.e., synthetic and natural minimally-sized biologically active fragments (MBAF) with pathogen-associated molecular patterns. In this respect, a very promising drug registered in Russia is based on the synthetic MBAF, glucosaminylmuramyldipeptide (GMDP), The liсopid immunomodulator. This is due to the fact that GMDP, being an active substance of Liсopid, is a highly specific ligand for the NOD2 receptor of innate immunity factors; it may cause activation of the NF-kB transcription factor, and production of multiple immunoregulatory cytokines. Clinical and immunological efficacy of Licopid application in conventional therapy of atopic allergic diseases (asthma, atopic dermatitis, atopic variant of acute obstructive bronchitis) is presented as an overview of pre-clinical and clinical trials.
About the Authors
N. V. Kolesnikova
Kuban State Medical Academy, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
PhD, MD (Biology), Professor, Department of Clinical Immunology, Allergy and Laboratory Diagnosis of FPC and PPS, Head of Central Research Laboratory,
Krasnodar
I. G. Kozlov
N.I. Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
PhD, MD (Medicine), Professor, Vice-President of Russian Society of Immunology, Head, Laboratory of Experimental Immunology and Immunopharmacology, Federal D. Rogachev Research and Clinical Center for Pediatric Hematology, Oncology and Immunology;
Head, Department of Pharmacology,
Moscow
S. V. Guryanova
M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Russian Federation
Russian Federation
PhD (Biology), Laboratory of Peptide Chemistry,
117997, Moscow, Mikhlukho-Maklay str., 16/10
E. A. Kokov
Kuban State Medical Academy, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
PhD (Medicine), Assistant Professor, Department of Clinical Immunology, Allergy and Laboratory Diagnosis of FPC and PPS,
Krasnodar
T. M. Andronova
CJSC Peptek
Russian Federation
Russian Federation
PhD (Chemistry), President,
Moscow
References
1. Гурьянова С.В., Козлов И.Г., Мещерякова Е.А., Алексеева Л.Г., Андронова Т.М. Глюкозаминилмурамилдипептид нормализует баланс Тh1/Th2 при атопической бронхиальной астме // Иммунология, 2009. № 5. С. 305-308. [Guryanova S.V., Kozlov I.G., Meshcheryakova E.A., Alekseeva L.G., Andronova T.M. Investigation into the influence of glucosaminylmuramyl dipeptide on the normalization of Th1/Th2 balance in patients with atopic bronchial asthma. Immunologiya = Immunology, 2009, no. 5, pp. 305-308. (In Russ.)]
2. Ильина Н.И. Эпидемия аллергии — в чем причины?// Российский аллергологический журнал, 2004. № 1. С. 37-41. [Ilyina N.I. Еpidemic of allergy – what are the reasons? Rossiyskiy allergologicheskiy zhurnal = Russian Allergy Journal, 2004, no. 1, pp. 37-41. (In Russ.)]
3. Козлов И.Г., Колесникова Н.В., Воронина Е.В., Гурьянова С.В., Андронова Т.М. Глюкозаминилмурамилдипептид и другие агонисты рецепторов врожденного иммунитета в патогенетической терапии атопических заболеваний // Аллергология и иммунология, 2013. Т. 14, № 4. С. 1-7. [Kozlov I.G., Kolesnikova N.V., Voronina E.V., Guryanova S.V., Andronova T.M. Glucosaminylmuramyldipeptide and other agonists of innate immunity receptors in the pathogenetic treatment of allergic diseases. Allergologiya i immunologiya = Allergology and Immunology, 2013, Vol. 14, no. 4, pp. 1-7. (In Russ.)]
4. Колесникова Н.В., Коков Е.А., Андронова Т.М., Гурьянова С.В., Мещерякова Е.А, Кокова Л.Н., Лесик Д.В. Регуляция мурамилдипептидами синтеза иммуноглобулина Е в эксперименте и клинике // Российский аллергологический журнал, 2008. № 5. C. 50-55. [Kolesnikova N.V., Kokov E.A., Andronova T.M., Guryanova S.V., Meshcheryakova E.A., Kokova L.N., Lesik D.V. Regulation by muramyldipeptides synthesis of immunoglobulin E in the experiment and clinic. Rossiyskiy allergologicheskiy zhurnal = Russian Allergy Journal, 2008, no. 5, pp. 50-55. (In Russ.)]
5. Колесникова Н.В., Коков Е.А., Кокова Л.Н., Чудилова Г.А., Андронова Т.М. Нарушения функциональной активности нейтрофилов у детей с атопическим дерматитом и их коррекция ликопидом // Кубанский научный медицинский вестник, 2008. № 3-4 (102-103). С. 113-117. [Kolesnikova N.V., Kokov Е.А., Kokova L.N., Chudilova G.A., Andronova T.M. [Disturbanses of the functional activity of neutrophils in children with atopic dermatitis and their correction by licopid. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Research Medical Bulletin, 2008, no. 3-4 (102-103), pp. 113-117. (In Russ.)]
6. Колесникова Н.В., Коков Е.А., Кокова Л.Н., Чудилова Г.А., Нехотина И.В. Экспериментальная оценка механизмов IgE-супрессирующих эффектов мурамилдипептидов // Кубанский научный медицинский вестник, 2010. № 1 (115). С. 48-51. [Kolesnikova N.V., Kokov E.A., Kokova L.N., Danilov G.A., Nehotina I.V. The experimental study of MDP in modulation of IgE-synthesis. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Research Medical Bulletin, 2010, no. 1 (115), pp. 48-51. (In Russ.)]
7. Колесникова Н.В., Кокова Л.Н., Коков Е.А., Нехотина И.В., Чудилова Г.А., Ломтатидзе Л.В., Сторожук С.В., Обухова Н.А. Иммунный статус детей с бронхиальной астмой и обструктивным бронхитом, сочетанными с хламидийной инфекцией // Кубанский научный медицинский вестник, 2011. № 2 (125). С. 88-91. [Kolesnikova N.V., Kokova L.N., Kokov E.A., Nehotina I.V., Chudilova G.A., Lomtatidze L.V., Storozhuk S.V., Obukhova N.A. Immune status of children with IgE-mediated chronic respiratory diseases, combine with chlamydial infection. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Research Medical Bulletin, 2011, no. 2 (125), pp. 88-91. (In Russ.)]
8. Колесникова Н.В., Коков Е.А., Кокова Л.Н. Перспективы использования мурамилдипептидов в лечении аллергических IgE-опосредованных заболеваний // Аллергология и иммунология, 2014. № 4. С. 286-287. [Kolesnikova N.V., Kokov E.A., Kokova L.N. Muramyldipeptide prospects for the use in the treatment of allergic IgE-mediated diseases. Allergologiya i immunologiya = Allergology and Immunology, 2014, no. 4, pp. 286-287. (In Russ.)]
9. Мизерницкий Ю.Л. Дифференциальная диагностика и дифференцированная терапия острой бронхиальной обструкции при ОРВИ у детей раннего возраста // Практическая медицина, 2014. № 9. С. 82-88. [Mizernitsky Yu.L. Differential diagnosis and differentiated treatment of acute bronchial obstruction with SARS in infants. Prakticheskaya meditsina = Practical Medicine, 2014, no. 9, pp. 82-88. (In Russ.)]
10. Ревякина В.А., Козлов И.Г., Воронина Е.В., Филатова Т.А., Сурков А.Г., Андронова Т.М. Возможности глюкозаминил-мурамилдипептида в лечении атопических заболеваний у детей // Вопросы практической педиатрии, 2009. Т. 4, № 4. С.3-10. [Revyakina V.A., Kozlov I.G., Voronina E.V., Filatova T.A., Surkov A.G., Andronov T.M. Features muramyldipeptide glucosamine in the treatment of atopic diseases in children. Voprosy prakticheskoy pediatrii = Problems of Practical Pediatrics, 2009, Vol. 4, no. 4, pp. 3-10. (In Russ.)]
11. Хаитов Р.М., Кубанова А.А. Атопический дерматит: рекомендации для практических врачей // Российский национальный согласительный документ по атопическому дерматиту. М.: Фармарус Принт, 2002. 192 с. [Khaitov R.M., Kubanova A.A. Atopic dermatitis: advice to practitioners. Russian national conciliation document on atopic dermatitis]. Moscow: Farmarus Print, 2002. 192 p.
12. Хаитов Р.М. Главная мишень иммуномодулирующего действия ГМДП (ликопида) // Иммунология, 1994. № 2. С. 47-50. [Khaitov R.M. The main target of immunomodulatory effects GMDP (licopid). Immunologiya = Immunology, 1994, no. 2, pp. 47-50. (In Russ.)]
13. Хутуева С.X., Федосеева В.Н. Аллерген-специфическая иммунотерапия бронхиальной астмы. М.: Экон, 2000. 252 c. [Hutueva S.X., Fedoseyeva V.N. Allergen-specific immunotherapy of asthma]. Moscow: Ekon, 2000. 252 p. (In Russ.)]
14. Boniface S., Koscher V. Mamessier E. Assesment of T-lympho-cyte cytokine production in induced sputum from asthmatics: a flow cytometry study. Clin. Exp. Allergy, 2003, no. 33, pp. 1238-1243.
15. Global Strategy for Asthma Management and Prevention “Global Initiative for Asthma (GINA)” Update. 2015.
16. Irifune K., Yokoyama A., Sakai K., Watanabe A., Katayama H., Ohnishi H., Hamada H., Nakajima M., Kohno N., Higaki J. Adoptive transfer of T-helper cell type 1 clones attenuates an asthmatic phenotype in mice. Eur. Respir. J., 2005, no. 25, pp. 653-659.
17. Khanferyan R., Kolesnikova N., Lesik D., DuBuske L.M. The role of NOD-2 Receptors in Modulation of IgE-synthesis. J. Allergy Clin. Immunol., 2008, no. 9, p. 4.
18. Martinez F.D. Development of wheezing disorders and asthma in preschool children. Pediatrics, 2002, Vol. 109, pp. 362-367.
19. Meshcheryakova E.A., Makarov E.A., Philpott D.J., Andronova T.M., Ivanov V.T. Evidence for correlation between the intensi-ties of adjuvant effects and NOD2 activation by monomeric, di-meric and lipophylic derivatives of N-acetylglucosaminyl-N-acetylmuramyl peptides. Vaccine, 2007, no. 25, pp. 4515-4520.
20. Valacer D.J. Childhood asthma: causes, epidemiological factors and complications. Drugs, 2000, Vol. 59, pp. 43-45.
Review
For citations:
Kolesnikova N.V., Kozlov I.G., Guryanova S.V., Kokov E.A., Andronova T.M. CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF MURAMYL DIPEPTIDE IN THE TREATMENT OF ATOPIC DISEASES. Medical Immunology (Russia). 2016;18(1):15-20. (In Russ.) https://doi.org/10.15789/1563-0625-2016-1-15-20
Views:
1291
Email this article 